版本:
中国

BRIEF-Immunovaccine announces positive phase 1 topline data for DepoVax-based respiratory syncytial virus vaccine candidate

Oct 13 Immunovaccine Inc :

* Immunovaccine announces positive phase 1 topline data for depovax(tm)-based respiratory syncytial virus vaccine candidate

* Immunovaccine Inc - vaccine had a positive safety profile and was well tolerated with no serious adverse events among all study participants Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐